0
2021
Oral Cancer Treatment Market

Oral Cancer Treatment Market

by Treatment (Chemotherapy, Immunotherapy, and Targeted Therapy), Age Group (30-49, 50-69 and 70<), and End User (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Store): Global Opportunity Analysis and Industry Forecast, 2021-2030

Report Code: A14903
Pages: 213
Dec 2021 | 2982 Views
Author(s) : Smita N , Onkar S
Tables: 111
Charts: 43
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Oral Cancer Treatment Market

Request Now !

Global oral cancer treatment market was valued at $ 1,710.53 million 2020, and is projected to reach $ 2,729.72 Million by 2030 registering a CAGR of 4.80% from 2021 to 2030.

Oral cancer includes cancers of the mouth and the back of the throat. Oral cancers develop on the tongue, the tissue lining the mouth and gums, under the tongue, at the Oral Cancer Treatment Market base of the tongue, and the area of the throat at the back of the mouth. Furthermore, oral cancer accounts for approximately 3% of all cancers diagnosed annually in the U.S, or about 53,000 new cases each year. In addition, oral cancer most often occurs in people over the age of 40 and affects more than twice as many men as women. Most oral cancers are related to tobacco use, alcohol use (or both), or infection by the human papilloma virus (HPV).

Oral-Cancer-Treatment-Market--2021-2030

Increase in demand for targeted mode of therapies, surge in the R&D activities for the development of novel drugs and therapies, high unmet need of treatment and increased expenditure for the development of healthcare infrastructure are the major factors attributable to the growth of oral cancer treatment market. Further, growing prevalence of oral or mouth cancer globally is a major factor fostering the growth of the market. Rising expenditure on the development of healthcare infrastructure, growing consumption of tobacco products such as cigarettes, cigars, pipes and chewing tobacco and upsurge in the special designation from regulatory authorities are other factors also raising the growth of the market. On the other hand, increasing personal disposable income coupled with rising prevalence of papillomavirus infection is other indirect cause that is expected to create lucrative growth opportunities for the market.

However, lack of awareness about oral cancer in the backward and underdeveloped areas will hamper the market growth. 

The outbreak of COVID-19 has disrupted workflows in the healthcare sector across the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of healthcare. Moreover, COVID-19 has positively impacted the oral cancer treatment market. When COVID-19 was first identified, many researchers redirected their focus to the study of this novel virus and the disease it causes. Severe COVID‐19 represents viral pneumonia from severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, which leads to acute respiratory distress syndrome. Its appearances can be viewed as a combination of the two processes that is viral pneumonia and acute respiratory distress syndrome. SARS‐CoV‐2 represents an ongoing worldwide threat, as this virus family has the potential to mutate and infect non‐immune population. Furthermore, Owing to the well-known major risk factors, oral cancer is considered a preventable disease and moreover, due to easy accessibility, it can be detected in early stages. Yet, majority of oral cancer cases in the developing countries are diagnosed in advanced stages, resulting in increased morbidity and mortality of oral cancer. Generally, dentists play a pivotal role in the early detection of oral cancer through opportunistic screening when a patient presents in a dental practice for routine care and by rapid referral of suspicious lesions. In the time of COVID-19, nevertheless, the whole world being in lockdown, and dental clinics are closed. Therefore, opportunities for screening the oral cavity might be significantly disrupted, and consequently diagnosis of malignant and/or potentially malignant lesions might be delayed, a matter that inevitably leads to a missed diagnosis of oral cancer or, at best, diagnosis later on but at a late stage.

Oral Cancer Treatment Market
By Drug Therapy

Your browser does not support the canvas element.

Chemotherapy segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Oral Cancer Treatment Market Segmentation  

The global oral cancer treatment market is segmented into drug type, age group, distribution channel, and region. Depending on treatment, the market is bifurcated into chemotherapy, immunotherapy, targeted therapy. The age group segment is further categorized into 30-49, 50-69 and 70<. By end user, it is fragmented into hospital pharmacies, drug stores & retail pharmacies, online stores. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Segment Review

On the basis of treatment, the radiation therapy segment was the major shareholder 2020. In oral cancer, it's usually used after surgery to prevent the cancer returning.

In throat cancer, it's often the first treatment to be given, in combination with chemotherapy medicine (chemoradiotherapy). The treatment is usually given every day over the course of 6 weeks, depending on the size of the cancer and how far it has spread.

Oral Cancer Treatment Market
By Distribution Channel

Your browser does not support the canvas element.

Hospital Pharmacies segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Snapshot of North America Oral Cancer Treatment Market  

Increase in demand for surgical therapies for the treatment of oral cancer and rise in investment by governments in research & development to improve treatments boost the global market. North America dominated the global market in 2020 and this trend is projected to continue during the forecast period owing to the rising health care investments in the region and prevalence of oral cancer. The oral cancer treatment market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period. Rise in tobacco usage, increase in smoking, rapidly expanding health care industry, growing patient population, and high unmet needs are likely to drive the oral cancer treatment market in the region. Further, favorable government policies and rise in disposal income are anticipated to propel the oral cancer treatment market in the region during the forecast period.

The key market players profiled in the report include Bristol-Myers Squibb Company Cipla Inc., Eli-Lilly, F. Hoffmann-La Roche    , Fresenius Kabi AG, Intas Pharmaceuticals Ltd, Merck & Co., Inc., Sanofi, Teva Pharmaceuticals Industries Ltd and Viatris Inc.

Oral Cancer Treatment Market
By Region

2030
North America 
Europe
Asia-Pacific
LAMEA

Asia-Pacific region would exhibit the highest CAGR of 5.4% during 2021-2030.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the global oral cancer treatment market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and products the market used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

Oral Cancer Treatment Market Report Highlights

Aspects Details
BY DRUG TYPE
  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
By Age Group
  • 30-49
  • 50-69
  • 70<
By End User
  • Hospital Pharmacies
  • Drug Stores & Retail Pharmacies
  • Online Stores
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players BRISTOL MAYERS SQUIBB COMPANY, CIPLA INC., ELI-LILLY, F-HOFFMANN-LA-ROCHE, FRESENIUS KABI AG, INTAS PHARMACEUTICALS LTD., MERCK & CO. INC., SANOFI S.A, TEVA PHARMACEUTICALS INDUSTRIES LTD, VIATRIS INC. (MYLAN N.V)
 

Loading Table Of Content...


 
 

Oral cancer includes cancers of the mouth and the back of the throat. Oral cancers develop on the tongue, the tissue lining the mouth and gums, under the tongue, at the base of the tongue, and the area of the throat at the back of the mouth. Furthermore, oral cancer accounts for roughly 3% of all cancers diagnosed annually in the U.S, or about 53,000 new cases each year.

Growing prevalence of oral or mouth cancer globally is a major factor fostering the growth of the market. Rising expenditure on the development of healthcare infrastructure, growing consumption of tobacco products such as cigarettes, cigars, pipes and chewing tobacco and upsurge in the special designation from regulatory authorities are other factors also raisingfueling the growth of the market. On the other hand, increasing personal disposable income coupled with rising prevalence of papillomavirus infection is other indirect cause that will create lucrative growth opportunities for the market. However, lack of awareness about the oral cancer in the backward and underdeveloped areas will hamper the market growth.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The total market value of Oral Cancer Treatment Market is $1,579.47 million in 2020.

A. The forcast period for Oral Cancer Treatment Market is 2021 to 2030

A. The market value of Oral Cancer Treatment Market in 2021 is $5,893.53 million.

A. The base year is 2020 in Oral Cancer Treatment Market

A. Top companies such as Apeptico Forschung Und Entwicklung GmBH, Bayer AG, General Electric Company, Glaxosmithkline Plc, Koninklijke Philips N.V., Linde Plc., Medtronic Plc., Ony Biotech Inc.Pfizer Inc. and Teva Pharmaceutical Industries Ltd. held a high market position in 2020.

A. On the basis of therapy, the medication segment was the major shareholder 2020, as various therapies were used as supportive treatment for lung injury. Depending on injury type, the direct injury acquired the largest share in 2020, and is expected to remain dominant throughout the forecast period. This is attributed to rise in incidence of pulmonary infections worldwide.

A. Rise in prevalence of lung-related diseases and increase in geriatric population. Furthermore, increase in awareness related to treatment of acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) is expected to notably contribute toward the growth of the global market.

A. Asia-Pacific accounted for the largest share of the global lung injury market in 2020, and is expected to remain dominant throughout the forecast period. This is attributed to the presence of large population base, increase in awareness associated with lung injury treatment, and rise in healthcare expenditure.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS

Purchase Full Report of
Oral Cancer Treatment Market

Start reading instantly.
This Report and over 19,603+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Dec 2022 - Dec 2023)
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Dec 2022 - Dec 2023)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Dec 2022 - Dec 2023)
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Dec 2022 - Dec 2023)
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Dec 2022 - Dec 2023)
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers